UK Markets closed
  • FTSE 100

    +87.24 (+1.19%)
  • FTSE 250

    +146.93 (+0.75%)
  • AIM

    +9.47 (+1.00%)

    +0.0040 (+0.34%)

    +0.0020 (+0.1587%)

    +379.42 (+1.61%)
  • CMC Crypto 200

    -23.03 (-3.42%)
  • S&P 500

    +0.57 (+0.01%)
  • DOW

    +8.77 (+0.03%)

    +0.46 (+0.42%)

    +3.90 (+0.21%)
  • NIKKEI 225

    +336.19 (+1.27%)

    +596.56 (+2.96%)
  • DAX

    +99.61 (+0.72%)
  • CAC 40

    +12.53 (+0.20%)

Outlook on the Enteral Feeding Devices Global Market to 2029 - Shift From Parenteral to Enteral Nutrition is Driving Growth

·6-min read
Company Logo
Company Logo

Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "Enteral Feeding Devices Market by Product, Age Group, Application, End User - Forecast to 2029" report has been added to's offering.

The enteral feeding devices market is expected to reach $4.72 billion by 2029 at a CAGR of 6.5% during the forecast period, 2022-2029.

Based on extensive primary and secondary research and an in-depth analysis of the market scenario, the report provides insights into key drivers, restraints, challenges, and opportunities in the enteral feeding devices market. The growth of the enteral feeding devices market is mainly attributed to the rising need for enteral feeding devices due to the rapidly growing aging population and the associated increase in the prevalence of chronic diseases, the shift from parenteral nutrition to enteral nutrition, technological advancements in enteral feeding devices, and the growing demand for enteral feeding in home care settings.

In addition, the growing scope of enteral nutrition in emerging countries is expected to create significant growth opportunities for the players operating in this market. However, insufficient reimbursements for enteral nutrition hinder the growth of this market to a certain extent.

By product, the enteral feeding pumps segment is slated to register the highest CAGR during the forecast period due to the advanced features, fewer complications, precision, safety, and feasibility of enteral feeding pumps.

By age group, the adults segment is expected to account for the largest share of the enteral feeding devices market in 2022. The segment's large share is attributed to the rising incidence of age-related conditions, such as diabetes, cancer, dementia, and gastrointestinal disorders, and the availability of general principles that minimize complications in providing enteral nutrition to adults.

By application, the oncology segment is expected to account for the largest share of the enteral feeding devices market in 2022. The large share of this segment is attributed to the continuously rising number of patients undergoing cancer treatments and later requiring artificial nutrition.

An in-depth geographic analysis of the enteral feeding devices market provides detailed qualitative and quantitative insights about the five major regions (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region.

North America is expected to account for the largest share of the enteral feeding devices market in 2022, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The key players operating in the enteral feeding devices market are Becton, Dickinson and Company (U.S.), Cardinal Health, Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), Avanos Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), B. Braun Melsungen AG (Germany), Moog Inc. (U.S.), Amsino International Inc. (U.S.), Cook Medical LLC (U.S.), and Applied Medical Technology, Inc. (U.S.).

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. The in creasing Aging Population and the Associated Rise in the Prevalence Of Chronic Diseases
4.2.2. Shift From Parenteral to Enteral Nutrition
4.2.3. Technological Advancements in Enteral Feeding Devices
4.2.4. Growing Demand for Enteral Feeding in Home Care Settings
4.3. Restraints
4.3.1. Insufficient Reimbursements for Enteral Nutrition
4.4. Opportunities
4.4.1. Growing Scope of Enteral Nutrition in Emerging Countries
4.5. Challenges
4.5.1. Complications Associated With Enteral Feeding Devices
4.6. Covid-19: Impact on the Enteral Feeding Devices Market

5. Global Enteral Feeding Devices Market, by Product
5.1. Introduction
5.2. Enteral Feeding Pumps
5.3. Enteral Feeding Tubes
5.3.1. Enterostomy Feeding Tubes Standard Enterostomy Feeding Tubes Standard Gastrostomy Tubes Standard Jejunostomy Tubes Standard Gastrojejunostomy Tubes Low-Profile Enterostomy Feeding Tubes Low-Profile Gastrostomy Tubes Low-Profile Jejunostomy Tubes Low-Profile Gastrojejunostomy Tubes
5.3.2. Nasoenteric Feeding Tubes Nasogastric Feeding Tubes Nasojejunal Feeding Tubes Nasoduodenal Feeding Tubes
5.3.3. Oroenteric Feeding Tubes
5.4. Enteral Syringes
5.5. Giving Sets/Administration Sets
5.6. Accessories

6. Global Enteral Feeding Devices Market, by Age Group
6.1. Introduction
6.2. Adults
6.3. Pediatrics

7. Global Enteral Feeding Devices Market, by Application
7.1. Introduction
7.2. Oncology
7.2.1. Head And Neck Cancers
7.2.2. Stomach And Gastrointestinal Cancers
7.2.3. Liver Cancers
7.2.4. Pancreatic Cancers
7.2.5. Esophageal Cancers
7.2.6. Other Cancers
7.3. Gastrointestinal Diseases
7.4. Neurological Disorders
7.5. Diabetes
7.6. Hypermetabolism
7.7. Other Applications

8. Global Enteral Feeding Devices Market, by End User
8.1. Introduction
8.2. Hospitals
8.3. Home Care Settings
8.4. Ambulatory Care Settings

9. Enteral Feeding Devices Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest Of Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.6. Middle East & Africa

10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis (2021)
10.4.1. Cardinal Health, Inc. (U.S.)
10.4.2. Fresenius Se & Co. KGaA (Germany)
10.4.3. B. Braun Melsungen AG (Germany)

11. Company Profiles
11.1. Becton, Dickinson and Company
11.1.1. Business Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.2. Cardinal Health, Inc.
11.2.1. Business Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.3. Fresenius Se & Co. KGaA
11.3.1. Business Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.4. Avanos Medical, Inc.
11.4.1. Business Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Strategic Developments
11.5. Boston Scientific Corporation
11.5.1. Business Overview
11.5.2. Financial Overview
11.5.3. Product Portfolio
11.6. CONMED Corporation
11.6.1. Business Overview
11.6.2. Financial Overview
11.6.3. Product Portfolio
11.7. B. Braun Melsungen AG
11.7.1. Business Overview
11.7.2. Financial Overview
11.7.3. Product Portfolio
11.8. Moog Inc.
11.8.1. Business Overview
11.8.2. Financial Overview
11.8.3. Product Portfolio
11.9. Amsino International, Inc.
11.9.1. Business Overview
11.9.2. Product Portfolio
11.9.3. Strategic Developments
11.10. Cook Medical LLC
11.10.1. Business Overview
11.10.2. Product Portfolio
11.11. Applied Medical Technology, Inc.
11.11.1. Business Overview
11.11.2. Product Portfolio
11.11.3. Strategic Developments

12. Appendix

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting